All India Organisation of Chemists and Druggists said on Thursday that there is no supply of drugs in India by the Haryana-based firm that manufactured cough syrups flagged by the World Health Organization (WHO) as “substandard products”.AIOCD said, “There is no supply of Maiden Pharmaceuticals Limited drugs in India, they only export their products, still, if any guideline is issued by the Drugs Controller General of India we will follow those guidelines.”The WHO issued an alert on Wednesday, saying that the cough syrups manufactured by Maiden Pharmaceuticals Limited could potentially be linked to the death of children in The Gambia.The WHO has listed Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup and Magrip N Cold Syrup as substandard paediatric medicines because they had “unacceptable amounts of diethylene glycol and ethylene glycol as contaminants.”The agency added, “To date, these four products have been identified in The Gambia, but may have been distributed, through informal markets, to other countries or regions.”Naresh Kumar Goyal, one of the directors of the Maiden Pharmaceuticals told, “We are trying to find out the situation because it cropped up only today morning.”He also said, “We are trying to find out with the buyer and all that what has happened exactly. We are not selling anything in India.”